Health Canada announced Wednesday that it has approved the use of the Pfizer-Biontech vaccine for people 12 years of age and older. The previous age threshold was 16 years old. Deputy Shirley Hilton, who heads the region’s task force, said local health officials are working on a process that will allow eligible teens to pre-register.
“Eligibility includes people aged 12 to 15 living in community care or developmental services facilities or with higher, higher or risky conditions,” Hilton told the region’s health board on Wednesday. evening.
Currently, the region’s vaccine pre-registration page indicates that eligible 12-15 year olds may be considered for vaccination in consultation with their health care provider. These healthcare providers are encouraged to email the area immunization team to arrange immunization at the Kitchener Health Sciences Clinic.
One group who can pre-register starting Thursday are people aged 50 and over in the Waterloo region, Hilton said.
“Opening pre-registration to additional groups helps the working group prepare for the next group to be vaccinated,” she said.
“People will be invited to make an appointment based on priority, and not necessarily when they have pre-registered.
Update on vaccine supply
Wednesday’s board of health meeting also included an update on the planned delivery of different brands of vaccines to the Waterloo region.
A Moderna vaccine shipment is expected the week of May 10, but Hilton said it was not clear when more shipments would arrive after that.
Astra-Zeneca’s supply in the Waterloo region is running out, Hilton said, adding that it was not clear when more shipments will arrive.
However, shipments of the Pfizer-Biontech vaccine are expected to be stable through the end of May. After that, Hilton said there would be a “significant increase”.
“Due to the stability of Pfizer, we will begin to transfer some of our Moderna clinics to Pfizer in the coming weeks. “
When asked if it was safe to mix doses of the vaccine – for example, to receive a dose of Pfizer-Biontech vaccine and a dose of Moderna – the region’s medical officer of health said clinical trials on this subject were in progress.
“In about two weeks, we should get expert advice from the National Immunization Advisory Committee on vaccine mixing and pairing,” said Dr. Hsiu-Li Wang.